Added to YB: 2025-02-27
Pitch date: 2024-02-25
LVTX [bullish]
LAVA Therapeutics N.V.
-36.32%
current return
Author Info
Biotenic is a freelance L/S biotech investment analyst sharing investment theses. Sign up for the newsletter.
Company Info
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments.
Market Cap
$24.7M
Pitch Price
$2.12
Price Target
N/A
Dividend
N/A
Sector
Biotechnology
Category
special_situation
LVTX Liquidation/Takeout Case
LVTX bullish: Biotech w/ $76.6M cash, $5M milestone incoming. Q4 burn $7.3M. 2 active partnered programs w/ milestone & royalty potential. PFE & JNJ deals noted. Takeout potential above market price, compelling CVR likely. Leases expiring, reducing liabilities. 10K filing soon may update financials slightly.
Read full article (1 min)